| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2011 | US20110190400 Novel Compounds for Treatment of Malignant Tumors |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190398 Use of immunosuppressant compounds in a new indication |
| 08/04/2011 | US20110190397 Methods for Concomitant Administration of Colchicine and a Second Active Agent |
| 08/04/2011 | US20110190396 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 08/04/2011 | US20110190395 Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/04/2011 | US20110190394 Carnitine granulate and methods for its production |
| 08/04/2011 | US20110190393 Novel and efficient method for the synthesis of an amino acid |
| 08/04/2011 | US20110190392 Polysaccharide Based Antimicrobial Formulations |
| 08/04/2011 | US20110190391 Ferrocene derivatives with anticancer activity |
| 08/04/2011 | US20110190390 Methods and materials for treating pancreatic cancer |
| 08/04/2011 | US20110190389 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| 08/04/2011 | US20110190388 Ursolic acid derivative and pharmaceutical composition thereof |
| 08/04/2011 | US20110190387 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/04/2011 | US20110190386 Aptamer Inhibitors of Osteopontin and Methods of Use Thereof |
| 08/04/2011 | US20110190385 Methods and Products for Reawakening Retrocyclins |
| 08/04/2011 | US20110190384 siRNA Specific to WT1 17AA(-)Isoform and Use Thereof |
| 08/04/2011 | US20110190383 Diagnostic, Prognostic and Therapeutic Uses of MIRs in Adaptive Pathways and/or Disease Pathways |
| 08/04/2011 | US20110190382 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/04/2011 | US20110190381 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 08/04/2011 | US20110190380 Methods for delivery of sirna to bone marrow cells and uses thereof |
| 08/04/2011 | US20110190378 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same |
| 08/04/2011 | US20110190377 Method for producing a cell and/or tissue and/or disease phase specific medicament |
| 08/04/2011 | US20110190376 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 08/04/2011 | US20110190375 Compositions comprising cmyc sirna and methods of use thereof |
| 08/04/2011 | US20110190374 Methods of treating a meiotic kinesin associated disease |
| 08/04/2011 | US20110190373 Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure |
| 08/04/2011 | US20110190372 Compositions and methods for treating inflammatory disorders |
| 08/04/2011 | US20110190370 Modulation of hif1(alpha) and hif2(alpha) expression |
| 08/04/2011 | US20110190369 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190368 Organosulfur Compounds, a Method of Making Organosulfur Compounds and their Use for Inhibiting the Growth of Tumour Cells |
| 08/04/2011 | US20110190367 Novel use of 3,3'-diindolylmethane |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190364 Benzimidazole modulators of vr1 |
| 08/04/2011 | US20110190363 Liquid formulations of bendamustine |
| 08/04/2011 | US20110190361 Tricyclic compound and pharmaceutical use thereof |
| 08/04/2011 | US20110190360 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | US20110190356 Compositions and Methods of Using (R)- Pramipexole |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190354 Glycyrrhetinic acid derivative and use thereof |
| 08/04/2011 | US20110190352 Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| 08/04/2011 | US20110190351 Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same |
| 08/04/2011 | US20110190350 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 08/04/2011 | US20110190349 Tetrahydro-pyran derivatives |
| 08/04/2011 | US20110190348 Methods for treating cns disorders |
| 08/04/2011 | US20110190347 Methods for treating neuropathic pain |
| 08/04/2011 | US20110190346 Diphenyl Substituted Alkanes as Flap Inhibitors |
| 08/04/2011 | US20110190345 Treatment of Psychosis with a 5HT2A Antagonist and a Metabotropic Glutamate Receptor Agonist or Potentiator |
| 08/04/2011 | US20110190344 Benzimidazole modulators of vr1 |
| 08/04/2011 | US20110190343 Hiv-1 fusion inhibitors and methods |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190338 Compounds and Compositions Useful in the Treatment of Malaria |
| 08/04/2011 | US20110190337 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 08/04/2011 | US20110190336 Azabenzimidazolones |
| 08/04/2011 | US20110190335 Nitrogenated 5-membered heterocyclic compound |
| 08/04/2011 | US20110190334 Heterocyclic Sulfonamide Derivatives |
| 08/04/2011 | US20110190333 Dihydrotetrabenanzine for the treatment of anxiety |
| 08/04/2011 | US20110190332 Dopamine receptor ligands with enhanced duration of action |
| 08/04/2011 | US20110190331 Peripheral opioid receptor antagonists and uses thereof |
| 08/04/2011 | US20110190330 Spirocyclic gpr40 modulators |
| 08/04/2011 | US20110190329 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 08/04/2011 | US20110190328 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide |
| 08/04/2011 | US20110190327 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 08/04/2011 | US20110190326 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 08/04/2011 | US20110190325 Compounds, their syntheses, and thier uses |
| 08/04/2011 | US20110190324 Methods of treating atherosclerosis |
| 08/04/2011 | US20110190323 Cortistatin analogues and syntheses thereof |
| 08/04/2011 | US20110190322 Purin derivatives for use in the treatment of fab-related diseases |
| 08/04/2011 | US20110190321 Predictive marker for egfr inhibitor treatment |
| 08/04/2011 | US20110190320 Compositions for Treating or Delaying the Onset of Hair Loss |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190318 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190316 Substituted pyridines, and use thereof as Gsk3 inhibitors |
| 08/04/2011 | US20110190315 Indoline scaffold shp-2 inhibitors and cancer treatment method |
| 08/04/2011 | US20110190314 Pharmaceutical compositions and their methods of use |
| 08/04/2011 | US20110190313 Treatment of Pulmonary Arterial Hypertension |
| 08/04/2011 | US20110190312 Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof |
| 08/04/2011 | US20110190311 Use of cdk inhibitor for the treatment of glioma |
| 08/04/2011 | US20110190310 Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators |
| 08/04/2011 | US20110190309 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190307 Assay |
| 08/04/2011 | US20110190306 Inhibitors of PLK |
| 08/04/2011 | US20110190305 Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same |
| 08/04/2011 | US20110190304 Disubstituted phthalazine hedgehog pathway antagonists |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190301 Substituted cyclopentanes or cyclopentanones as therapeutic agents |
| 08/04/2011 | US20110190300 Amide compounds and the use thereof |
| 08/04/2011 | US20110190299 Thiazolidinone derivative |
| 08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 08/04/2011 | US20110190297 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 08/04/2011 | US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190295 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190293 Quinazolinone Compounds as Anticancer Agents |